Rationing of drugs for rare diseases
Pharmacoeconomics
.
2006;24(4):315-6.
doi: 10.2165/00019053-200624040-00001.
Author
Dyfrig Hughes
PMID:
16605277
DOI:
10.2165/00019053-200624040-00001
No abstract available
Publication types
Editorial
MeSH terms
Cost-Benefit Analysis
Health Care Rationing*
Health Services Accessibility
Humans
Orphan Drug Production / economics*
Patient Rights
Rare Diseases / drug therapy
Rare Diseases / economics*
Risk Sharing, Financial